Ultrasound-Assisted Cerium-Doped Zeolite Nanocomplex Attenuates Adenomyosis via Wnt/β-Catenin Pathway Inhibition and IGFBP5 Downregulation in SFRP4⁺ NKT Cells
article
OA: gold
CC0
AI-generated summary
Ultrasound-assisted synthesized cerium-doped zeolite nanocomplexes attenuated adenomyosis by inhibiting the Wnt/β-catenin pathway and downregulating IGFBP5 in SFRP4⁺ NKT cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Adenomyosis is a chronic gynecological disorder characterized by ectopic endometrial tissue within the myometrium, leading to pelvic pain, menorrhagia, and infertility. Increasing evidence implicates dysregulated Wnt/β-catenin signaling and aberrant activation of SFRP4+ natural killer T (NKT) cells in disease progression. This study reports the ultrasound-assisted synthesis of a cerium-doped zeolite nanocomplex (Ce-ZNC) and evaluates its therapeutic efficacy in experimental models of adenomyosis. Ce-ZNC was synthesized via an ultrasound-assisted doping approach and characterized using transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), dynamic light scattering (DLS), and polydispersity index (PDI) analysis. In vitro studies were conducted on human peripheral blood mononuclear cell (PBMC)-derived SFRP4⁺ NKT cells. In vivo efficacy was evaluated in a murine adenomyosis model. IGFBP5 expression and Wnt/β catenin signaling components were analyzed by RT-qPCR and Western blotting. Histological and cytokine analyses were performed to assess fibrosis and inflammation. Ce-ZNC exhibited spherical morphology with nanoscale dimensions and good colloidal stability. Treatment resulted in a dose-dependent suppression of IGFBP5 expression and inhibition of Wnt/β-catenin signaling. In vivo administration significantly reduced uterine fibrosis, glandular invasion, and inflammatory cytokine levels. These findings suggest that Ce-ZNC exerts immunomodulatory and anti-fibrotic effects in adenomyosis. While promising, further studies are required to elucidate biodistribution, long-term safety, and translational potential in human models.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Adenomyosis and Infertility—Review of Medical and Surgical Approaches via openalex
- Adenomyosis incidence, prevalence and treatment: United States population-based study 2006–2015 via openalex
- Assessment of quality of sexual life in women with adenomyosis via openalex
- Developmental Toxicant Exposure Is Associated with Transgenerational Adenomyosis in a Murine Model via openalex
- Immunopathology and Therapeutic Perspectives of Endometriosis: Scientific Gaps and Emerging Advances in Translational Immunotherapy via openalex
- Impact of Adenomyosis on Infertile Patients-Therapy Options and Reproductive Outcomes via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Prevalence of adenomyosis in women undergoing surgery for endometriosis via openalex
- Proteomic detection of COX-2 pathway-related factors in patients with adenomyosis via openalex
- Unveiling the Pathogenesis of Adenomyosis through Animal Models via openalex
- β-catenin activates TGF-β-induced epithelial–mesenchymal transition in adenomyosis via openalex
- W4407792278 via openalex
- W4409602952 via openalex
- W4412706660 via openalex
- W2091430600 via openalex
- W2922267617 via openalex
- W4310448248 via openalex
- W4316669079 via openalex
- W4389099323 via openalex
- W4390226298 via openalex
- W4392886192 via openalex
- W4396743501 via openalex
- W4403039151 via openalex
- W4406664253 via openalex
Source provenance
- openalex
- last seen: 2026-08-30T06:00:46.221890+00:00
License: CC0
· commercial use OK